Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestle, GE diagnostics

This article was originally published in The Tan Sheet

Executive Summary

General Electric's centralized R&D organization and the Nestle Research Center will collaborate to better understand the relationships between physical make-up, metabolism, lifestyle and nutrition, the firms announce May 14. The partnership brings together Switzerland-based Nestle's expertise in health and nutrition with London-based GE's diagnostics work, the companies say. Nestle scientists will use GE's Lunar iDXA imaging technology system to measure body fat, muscle and bone mineral density and study correlations between lifestyle habits, body composition and metabolic data to better comprehend biological health drivers, the firms say. The firms aim for the results to direct development of non-invasive, quick and accurate clinical assessment tools to evaluate nutritional impact on metabolism...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101670

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel